Next-Gen Formulation Sourcing & R&D Strategy

Reformulation has become the defining R&D mandate of the decade. GLP-1-driven demand for "better-for-you" products, FDA's 2028 "healthy" claim deadline, and alt-protein sensory failures are all colliding on the same R&D benches at once. Most companies chasing a stalled launch don't actually have an ingredient problem — they have an empty seat problem. The fastest way to protect a launch timeline in 2026 is sourcing the specialized formulation and R&D talent a generalist recruiter can't reach.

That's the shift this hub is built around. Four forces are converging on the same thin bench of scientists and leaders, and each one is quietly turning into a staffing crisis before anyone calls it that.

Why R&D Sourcing Broke in 2026

For most of the last decade, ingredient formulation and R&D staffing moved at a predictable pace: a role opened, a generalist recruiter ran a keyword search against active job seekers, and a candidate showed up in a few months. That model was already strained. Now it's failing outright, for one simple reason — the roles themselves have gotten harder to define, let alone source for.

A GLP-1 nutrient-density reformulation scientist, a sodium-reduction specialist who can hit an FDA compliance deadline, a clean-label flavor-masking expert who can save an alt-protein product at the sensory panel, and a VP of R&D who can run all of it — these aren't interchangeable "food scientist" reqs. Each demands a different technical lens, and the people who have it are almost never active candidates. They're already running critical reformulation programs at a competitor, well compensated, not browsing job boards, and immune to the tenth generic recruiter message they got this month.

Compounding the problem: these four pressures are landing on R&D teams that are already lean. Most food and beverage companies right-sized their innovation functions over the last few years, which means there's less internal bench strength to absorb a sudden, technical, deadline-driven mandate. When a GLP-1 reformulation project, a compliance deadline, and a stalled alt-protein launch all need attention from the same six-person R&D team, something gets deprioritized — and it's usually the project that was hardest to staff correctly in the first place.

The Four Fault Lines in Formulation Talent Right Now

Fault Line 1: The GLP-1 Reformulation Talent Gap

GLP-1 adoption has rewritten what "better-for-you" means to consumers almost overnight — more protein, less added sugar, higher satiety, smaller portions that still feel satisfying. Brands are racing to reformulate entire portfolios around those expectations, and most are discovering their R&D bench simply isn't built for it. Nutrient-density and satiety formulation is a specialized skill set, and the scientists who have it are already spoken for.

Read the full breakdown: The GLP-1 Reformulation Crunch: Why Empty R&D Benches Are Delaying "Better-For-You" Product Launches

Fault Line 2: The FDA 2028 "Healthy" Deadline

FDA's updated "healthy" claim rule takes effect in 2028, and sodium and sugar reduction reformulation is the quiet staffing crisis sitting behind it. This isn't a labeling update — it's a compliance cliff that requires product reformulation at scale, on a fixed timeline, using a narrow pool of sodium- and sugar-reduction specialists that every manufacturer in the category is now competing for at once.

Read the full breakdown: FDA's 2028 "Healthy" Deadline Is a Staffing Crisis in Disguise: Sourcing Sodium & Sugar Reduction Specialists Before the Compliance Cliff

Fault Line 3: The Alt-Protein Sensory Panel Failure

Alt-protein and plant-based launches keep dying at the same stage: the sensory panel. Texture and flavor-masking are the hardest unsolved problems in clean-label formulation, and most R&D teams are trying to solve them with generalist food scientists instead of the specific talent that actually closes the gap — sensory scientists and flavor-masking specialists who've done this exact work before, not adjacent work.

Read the full breakdown: Why Alt-Protein Launches Keep Failing at the Sensory Panel: The Hidden Talent Gap Behind Clean-Label Texture & Flavor Masking

Fault Line 4: The Real Cost of a Vacant VP of R&D Seat

Every one of the three fault lines above gets worse the longer an R&D leadership seat sits empty. A vacant VP of R&D role doesn't just sit quietly on an org chart — it stalls every reformulation project underneath it, and the launch-delay penalty compounds every week the seat stays open. This is the ROI case for treating R&D executive search as a speed problem, not a formality.

Read the full breakdown: The Cost of a Vacant VP of R&D Seat: Quantifying Product Launch Delay Penalties in the Reformulation Race

Why a Specialist Finds R&D Leaders a Generalist Can't

R&D and formulation leadership isn't a side practice for us — it's the work. People Capital was founded in 2007 and has operated exclusively in food, beverage, flavor, ingredient, color, nutraceutical, agriculture, chemical, pharmaceutical, and pet food since day one. Every search we've run in that time has fed the same growing network of scientists, technical leaders, and innovation executives, which is why a GLP-1 nutrient-density specialist or a clean-label sensory expert is rarely a cold introduction for us — they're already a known relationship.

That distinction matters more than ever in a reformulation cycle this technical. A GLP-1 nutrient-density scientist, a sodium-reduction specialist, a clean-label sensory expert, and a VP of R&D who can lead all three each require a different evaluation lens — and the strongest candidates are passive. They're not responding to job postings. They're responding to a recruiter who understands the actual work well enough to have a real conversation about it.

Proof. A global color and ingredient manufacturer — products in 130 countries, 1,200+ employees — had two VP of R&D roles open for six months, worked through an internal team and two other recruiting firms, and had nothing to show for it. People Capital was engaged and, in under two weeks, presented one exceptional off-market candidate: a senior director at a leading natural color company who wasn't on anyone's radar. She was hired to fill both roles as VP of Global Innovation and is still leading global R&D innovation there today.

Our typical search runs under six weeks, because cultural fit, work style, and technical depth are verified before a candidate is ever presented — not after.

Building an R&D Talent Strategy for the Reformulation Era

The four issues above aren't separate problems — they're one problem showing up in four places. Every food and beverage company navigating GLP-1 reformulation, the 2028 compliance deadline, or an alt-protein sensory failure is drawing from the same thin, highly specialized pool of talent, and every week a critical seat stays open is a week a competitor's launch gets there first.

If you're staffing a formulation team ahead of a launch, racing a compliance deadline, or trying to fill an R&D leadership seat that's been open too long, that's exactly when a specialized search partner earns its keep — before the vacancy becomes the reason a launch date slips, not after.

Let's build the R&D bench your 2026 launch calendar actually requires.

Start a Confidential Search